These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 30846988
1. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome. Davies R, Sarkar I, Hammenfors D, Bergum B, Vogelsang P, Solberg SM, Gavasso S, Brun JG, Jonsson R, Appel S. Front Immunol; 2019; 10():281. PubMed ID: 30846988 [Abstract] [Full Text] [Related]
2. Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature. Davies R, Hammenfors D, Bergum B, Vogelsang P, Gavasso S, Brun JG, Jonsson R, Appel S. Eur J Immunol; 2018 Jul; 48(7):1217-1227. PubMed ID: 29604049 [Abstract] [Full Text] [Related]
3. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome. Vogelsang P, Karlsen M, Brun JG, Jonsson R, Appel S. Arthritis Res Ther; 2014 Aug 11; 16(4):R166. PubMed ID: 25113744 [Abstract] [Full Text] [Related]
4. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome. Maria NI, Steenwijk EC, IJpma AS, van Helden-Meeuwsen CG, Vogelsang P, Beumer W, Brkic Z, van Daele PL, van Hagen PM, van der Spek PJ, Drexhage HA, Versnel MA. Ann Rheum Dis; 2017 Apr 11; 76(4):721-730. PubMed ID: 27672125 [Abstract] [Full Text] [Related]
5. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis. Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm VASH, van Hagen PM, Groot N, Kamphuis S, van Daele PLA, Versnel MA. J Autoimmun; 2018 Jul 11; 91():97-102. PubMed ID: 29673738 [Abstract] [Full Text] [Related]
6. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients. Shimizu T, Nakamura H, Takatani A, Umeda M, Horai Y, Kurushima S, Michitsuji T, Nakashima Y, Kawakami A. Clin Exp Immunol; 2019 Apr 11; 196(1):39-51. PubMed ID: 30446998 [Abstract] [Full Text] [Related]
7. Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets. Ritter J, Szelinski F, Aue A, Stefanski AL, Rincon-Arevalo H, Chen Y, Nitschke E, Dang VD, Wiedemann A, Schrezenmeier E, Lino AC, Dörner T. J Autoimmun; 2024 Jul 11; 147():103243. PubMed ID: 38788537 [Abstract] [Full Text] [Related]
8. Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome. Zheng L, Zhang Z, Yu C, Yang C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun 11; 109(6):844-50. PubMed ID: 20399690 [Abstract] [Full Text] [Related]
9. Aberrant signaling of immune cells in Sjögren's syndrome patient subgroups upon interferon stimulation. Sarkar I, Davies R, Aarebrot AK, Solberg SM, Petrovic A, Joshi AM, Bergum B, Brun JG, Hammenfors D, Jonsson R, Appel S. Front Immunol; 2022 Jun 11; 13():854183. PubMed ID: 36072585 [Abstract] [Full Text] [Related]
10. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome. Kwok SK, Cho ML, Her YM, Oh HJ, Park MK, Lee SY, Woo YJ, Ju JH, Park KS, Kim HY, Park SH. Arthritis Res Ther; 2012 Mar 14; 14(2):R64. PubMed ID: 22417709 [Abstract] [Full Text] [Related]
11. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome. Maria NI, Brkic Z, Waris M, van Helden-Meeuwsen CG, Heezen K, van de Merwe JP, van Daele PL, Dalm VA, Drexhage HA, Versnel MA. Ann Rheum Dis; 2014 Jun 14; 73(6):1052-9. PubMed ID: 23831963 [Abstract] [Full Text] [Related]
12. Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren's syndrome. Sun JL, Zhang HZ, Liu SY, Lian CF, Chen ZL, Shao TH, Zhang S, Zhao LL, He CM, Wang M, Zhang W, Chen H, Zhang FC. Ann Rheum Dis; 2020 Apr 14; 79(4):518-524. PubMed ID: 32114510 [Abstract] [Full Text] [Related]
18. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators. Lopes AP, Bekker CPJ, Hillen MR, Blokland SLM, Hinrichs AC, Pandit A, Kruize AA, Radstake TRDJ, van Roon JAG. Front Immunol; 2021 Oct 14; 12():701656. PubMed ID: 34413853 [Abstract] [Full Text] [Related]